Economic decision-making involves weighing up differently beneficial alternatives to maximise payoff. This sometimes requires the ability to forego one's desire for immediate satisfaction. This ability is considered cognitively challenging because it not only requires inhibiting impulses, but also evaluating expected outcomes in order to decide whether waiting is worthwhile. We tested four parrot species in a token exchange task. The subjects were first trained to exchange three types of tokens for a food item of low, medium, and high value and successfully learned to exchange these in an order according to their value. Subsequently, they were confronted with a choice between a food item and a token that could be exchanged for higher-quality food. In additional control conditions however, choosing a token led to an equal or lower payoff. Individuals of all species were capable of deciding economically, yet only large macaws outperformed the other species in one of the crucial controls. For some individuals, particularly African grey parrots, the token apparently had an intrinsic value, which prevented them from choosing economically in some control conditions and which should be considered as potentially confounding by future token exchange studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105634 | PMC |
http://dx.doi.org/10.1038/s41598-018-30933-5 | DOI Listing |
Foods
January 2025
Department of Administration, Faculty of Administration and Economics, University of Santiago of Chile (USACH), Santiago 9170020, Chile.
This study evaluated how healthy lifestyle motivators (MHLs) influence the Peruvian market's willingness to consume healthy food (WCHBF). The main objective was to analyze the relationship of variables, such as attitude (ATT), perceived behavioral control (PBC), self-identity (SI), and moral norms (MN) with the WCHBF. This study adopted a quantitative, non-experimental, and cross-sectional approach, using a self-administered questionnaire for data collection.
View Article and Find Full Text PDFInt J Mol Sci
December 2024
Faculty of Medicine, Institute of Translational and Clinical Research, University of Maribor, Taborska ulica 8, 2000 Maribor, Slovenia.
Over the past century, numerous methods for assessing cell viability have been developed, and there are many different ways to categorize these methods accordingly. We have chosen to use the Organisation for Economic Co-operation and Development (OECD) classification due to its regulatory importance. The OECD categorizes these methods into four groups: non-invasive cell structure damage, invasive cell structure damage, cell growth, and cellular metabolism.
View Article and Find Full Text PDFTrials
January 2025
Palliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Background: A key challenge for many critical care clinical trials is that some patients will die before their outcome is fully measured. This is referred to as "truncation due to death" and must be accounted for in both the treatment effect definition (i.e.
View Article and Find Full Text PDFBackground: The Prostatype score (P-score) is a prognostic biomarker that integrates a three-gene (IGFBP3, F3, and VGLL3) signature derived from prostate biopsy samples, with key clinical parameters, including prostate-specific antigen (PSA) levels, Gleason grade, and tumor stage at diagnosis. The test has demonstrated superior predictive accuracy for prostate cancer outcomes compared with traditional risk categorization systems such as D'Amico. Notably, it reclassifies a higher proportion of patients into the low-risk category, making them eligible for active surveillance.
View Article and Find Full Text PDFJCO Oncol Pract
January 2025
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
The direct and indirect financial burden of cancer care, from medication costs to lost wages, results in financial toxicity for patients. Despite the growing recognition of financial toxicity as a problem for patients, there are few solutions available at the point of care. Structured cost conversations between oncologists and patients to help identify financial toxicity and intervene early when it is recognized have been posited as a patient facing intervention.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!